Interim Report 2026
Filed with HKEX · Stock code 1498 · · 68 pages · English
Earlier from PuraPharm
- Proposed change of auditor
- Resignation of chief financial officer, change of company secretary and authorised representative
- (I) proposed re-election of retiring directors; (II) proposed grant of general mandates to buy back shares and issue new shares; (iii) proposed refreshment of Scheme Mandate Limit under the share option scheme; (IV) proposed change of company name; (v) proposed amendments to the Articles of Association of the company; and notice of annual general meeting
- Extension of long stop date for connected transaction
- PuraPharm: Connected transaction - acquisition of intellectual properties
Later from PuraPharm
- Notification Letter to Registered Shareholders and Change Request Form - 2026 Interim Report
- Notification Letter to Non-registered Shareholders and Request Form - 2026 Interim Report
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Proposed change of auditor and notice of extraordinary general meeting
- Notice of extraordinary general meeting
Follow PuraPharm into a list and get an email when it puts out news.
Follow PuraPharm